Sign in

CIK 0001761612

  • Non-accelerated filer
  • Smaller reporting company

BICYCLE THERAPEUTICS PLC

Sign in to watch
Ticker
BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1223261503
Business address
BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
Former names
BICYCLE THERAPEUTICS Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$64,039
in 7 filings, $7K under 10b5-1 plans

Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-07-03 Keen Nicholas CHIEF SCIENTIFIC OFFICER Sale −779 $19.64 $15K 62,024
2024-04-03 Keen Nicholas CHIEF SCIENTIFIC OFFICER Sale −790 $23.81 $19K 62,803
2024-01-03 Keen Nicholas Chief Scientific Officer Sale −2,640 $17.50 $46K 63,593
2024-01-02 Keen Nicholas Chief Scientific Officer Grant or award +28,000 66,233
2024-01-02 Keen Nicholas Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +56,000 56,000
2023-10-03 Keen Nicholas Chief Scientific Officer Sale −272 $20.00 $5K 38,233
2023-07-03 Keen Nicholas Chief Scientific Officer Sale −336 $25.10 $8K 38,505
2023-04-03 Keen Nicholas Chief Scientific Officer Sale −319 $21.11 $7K 38,841
2023-01-03 Keen Nicholas Chief Scientific Officer Grant or award +17,500 40,977
2023-01-03 Keen Nicholas Chief Scientific Officer Sale −1,817 $29.06 $53K 39,160
2023-01-03 Keen Nicholas Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +35,000 35,000
2022-01-03 Keen Nicholas Chief Scientific Officer Grant or award +15,000 23,477
2022-01-03 Keen Nicholas Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +30,000 30,000
2021-12-21 Keen Nicholas Chief Scientific Officer Exercise or conversion +15,477 $14.00 $217K 15,477
2021-12-21 Keen Nicholas Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −15,477 161,927
2021-10-05 Keen Nicholas Chief Scientific Officer Sale −2,178 $45.10 $98K 0
2021-10-01 Keen Nicholas Chief Scientific Officer Sale −1,188 $45.00 $53K 2,178
2021-09-16 Keen Nicholas Chief Scientific Officer Sale −1,955 $45.01 $88K 3,366
2021-09-15 Keen Nicholas Chief Scientific Officer Sale −3,000 $45.00 $135K 5,321
2021-09-02 Keen Nicholas Chief Scientific Officer Sale −10,000 $40.00 $400K 8,321

Page 1 of 2 · 29 trades